1. Home
  2. BVS vs ULCC Comparison

BVS vs ULCC Comparison

Compare BVS & ULCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$13.63

Market Cap

982.2M

Sector

Health Care

ML Signal

HOLD

Logo Frontier Group Holdings Inc.

ULCC

Frontier Group Holdings Inc.

HOLD

Current Price

$6.28

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BVS
ULCC
Founded
2011
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
982.2M
1.1B
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
BVS
ULCC
Price
$13.63
$6.28
Analyst Decision
Strong Buy
Hold
Analyst Count
3
8
Target Price
$14.00
$5.21
AVG Volume (30 Days)
460.2K
2.2M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
163.46
N/A
EPS
0.52
N/A
Revenue
$568,087,000.00
$3,724,000,000.00
Revenue This Year
$7.52
$23.76
Revenue Next Year
$7.06
$11.48
P/E Ratio
$26.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.26
$3.02
52 Week High
$15.89
$8.41

Technical Indicators

Market Signals
Indicator
BVS
ULCC
Relative Strength Index (RSI) 50.84 58.65
Support Level $13.44 $5.39
Resistance Level $14.71 $6.66
Average True Range (ATR) 0.51 0.23
MACD -0.08 0.10
Stochastic Oscillator 51.85 95.45

Price Performance

Historical Comparison
BVS
ULCC

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

About ULCC Frontier Group Holdings Inc.

Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos, and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. The majority of revenue is from Domestic flight follow by International.

Share on Social Networks: